{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:24:45Z","timestamp":1793946285300,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016850","name":"Beauty Of Sight Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajo.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:19:23Z","timestamp":1775603963000},"page":"270-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In Vitro Study of Microbial Growth in Artificial Tears Using a Novel Kinetic and Culture-Based Model"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0408-697X","authenticated-orcid":false,"given":"Felipe Echeverri","family":"Tribin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-5813","authenticated-orcid":false,"given":"Heather","family":"Durkee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7475-2990","authenticated-orcid":false,"given":"Alexander","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1032-607X","authenticated-orcid":false,"given":"Alison","family":"Rodriguez Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-7813","authenticated-orcid":false,"given":"Mariela C.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3716-3027","authenticated-orcid":false,"given":"Salomon","family":"Merikansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Maestre-Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Amescua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2026.04.002_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OPTO.S350185","article-title":"Artificial tears: a systematic review","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optom (Auckl)"},{"key":"10.1016\/j.ajo.2026.04.002_bib0002","first-page":"1419","article-title":"Artificial tears potpourri: a literature review","volume":"8","author":"Moshirfar","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.04.002_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jtos.2012.12.002","article-title":"Dry eye disease and microbial keratitis: is there a connection?","volume":"11","author":"Narayanan","year":"2013","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.002_bib0004","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms24032758","article-title":"A critical appraisal of the physicochemical properties and biological effects of artificial tear ingredients and formulations","volume":"24","author":"Weng","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.002_bib0005","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.002_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/ICU.0000000000001109","article-title":"A comprehensive update on over the counter artificial tears","volume":"36","author":"Simon","year":"2025","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.04.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/aos.17500","article-title":"Preservatives in artificial tears: assessing impact on dry eye symptoms: findings from 67\u2009951 questionnaire responses-project FOREVER","author":"Sj\u00f6","year":"2025","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.04.002_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061289","article-title":"Categorization of marketed artificial tear formulations based on their ingredients: a rational approach for their use","volume":"10","author":"Kathuria","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.002_bib0009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamaophthalmol.2024.0259","article-title":"Clinical features and treatment outcomes of carbapenem-resistant Pseudomonas aeruginosa keratitis","volume":"142","author":"Tribin","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2023.06.003","article-title":"Association of Artificial Tears with ocular and systemic infection: carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) outbreak","volume":"130","author":"Velcani","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.04.002_bib0011","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/OPTH.S377960","article-title":"Propylene glycol and hydroxypropyl guar nanoemulsion - safe and effective lubricant eye drops in the management of dry eye disease","volume":"16","author":"Srinivasan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"13","key":"10.1016\/j.ajo.2026.04.002_bib0012","first-page":"259","article-title":"Comparison of Genaqua\u00ae\u2013Preserved Genteal\u00ae in multidose bottles vs preservative\u2013Free Tears Naturale\u00ae in single dose units in patients with moderate to severe dry eye","volume":"47","author":"Lanz","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.04.002_bib0013","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2147\/OPTH.S256480","article-title":"Safety and efficacy of a preservative-free artificial tear containing carboxymethylcellulose and hyaluronic acid for dry eye disease: a randomized, controlled, multicenter 3-month study","volume":"14","author":"Aragona","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.04.002_bib0014","unstructured":"Food and Drug Administration, Department of Health and Human Services. Ophthalmic drug products for over-the-Counter Human use, 21 CFR \u00a7 349. Food and Drug Administration, Department of Health and Human Services. Washington, DC: Office of the Federal Register National Archives and Records Administration; 2025. 21."},{"issue":"8","key":"10.1016\/j.ajo.2026.04.002_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.12.8.5","article-title":"Effects of carboxymethylcellulose artificial tears on ocular surface microbiome diversity and composition, a randomized controlled trial","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2026.04.002_bib0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","article-title":"Ocular Benzalkonium Chloride Exposure: problems and Solutions","volume":"36","author":"Goldstein","year":"2022","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.002_bib0017","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2008.144469","article-title":"Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers","volume":"92","author":"Kim","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.04.002_bib0018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bjo.80.7.588","article-title":"Control of microbial contamination in unpreserved eyedrops","volume":"80","author":"Oldham","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.04.002_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31351\/vol20iss2pp91-95","article-title":"Microbial contamination of eye drops in out patient in Iraq","volume":"20","author":"Razooki","year":"2011","journal-title":"Iraqi J Pharm Sci"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.002_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1097\/01.icl.0000181819.63425.a6","article-title":"Comparison of initial treatment response to two enhanced-viscosity artificial tears","volume":"32","author":"Noecker","year":"2006","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.002_bib0022","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.04.002_bib0023","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.04.002_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2026.04.002_bib0025","unstructured":"Bian Y., Kaufman A.R., Halfpenny C., et al. Preservatives in Topical ophthalmic medications. EyeWiki. American Academy of Ophthalmology. Published online October 13, 2025. Accessed March 31, 2026. https:\/\/eyewiki.aao.org\/Preservatives_in_Topical_Ophthalmic_Medications."},{"issue":"1","key":"10.1016\/j.ajo.2026.04.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.optom.2023.100481","article-title":"Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells","volume":"17","author":"Hedengran","year":"2024","journal-title":"J Optom"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.002_bib0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.002_bib0028","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/15569520902995834","article-title":"Ocular preservatives: associated risks and newer options","volume":"28","author":"Kaur","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"issue":"8","key":"10.1016\/j.ajo.2026.04.002_bib0029","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41433-019-0665-y","article-title":"Eye drop technique and patient-reported problems in a real-world population of eye drop users","volume":"34","author":"Mehuys","year":"2020","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.ajo.2026.04.002_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102176","article-title":"Highlighting the microbial contamination of the dropper tip and cap of in-use eye drops, the associated contributory factors, and the risk of infection: a past-30-years literature review","volume":"14","author":"Iskandar","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99892-8","article-title":"Contamination of multi dose eyedrops in the intra and perioperative context","volume":"11","author":"Daehn","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2026.04.002_bib0032","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1248\/bpb.b16-00688","article-title":"The risk of microbial contamination in multiple-dose preservative-free ophthalmic preparations","volume":"40","author":"Saisyo","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ajo.2026.04.002_bib0033","first-page":"1","article-title":"Could a preservative have prevented the extremely-drug resistant Pseudomonas aeruginosa artificial tears associated eye infection outbreak of 2023?","author":"Romanowski","year":"2025","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2026.04.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178691","article-title":"The use of Gompertz models in growth analyses, and new Gompertz-model approach: an addition to the Unified-Richards family","volume":"12","author":"Tj\u00f8rve","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2026.04.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108335","article-title":"The Gompertz model and its applications in microbial growth and bioproduction kinetics: past, present and future","volume":"72","author":"Wang","year":"2024","journal-title":"Biotechnol Adv"},{"issue":"4","key":"10.1016\/j.ajo.2026.04.002_bib0036","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.ico.0000183538.53017.69","article-title":"Are multidose over-the-counter artificial tears adequately preserved?","volume":"25","author":"Charnock","year":"2006","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2026.04.002_bib0037","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/jop.2012.0041","article-title":"Antimicrobial activity of a new preservative for multiuse ophthalmic solutions","volume":"29","author":"Ghelardi","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.002_bib0038","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ceo.14113","article-title":"Infectious keratitis: a review","volume":"50","author":"Cabrera-Aguas","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.002_bib0039","article-title":"Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital","volume":"2","author":"Chantra","year":"2022","journal-title":"Adv Ophthalmol Pract Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:26:53Z","timestamp":1793942813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S0002939426001741"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.04.002","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Study of Microbial Growth in Artificial Tears Using a Novel Kinetic and Culture-Based Model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}